Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-01-06Clinical Trial Update: A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating EpCAM-targeted CAR T cells across multiple cancers, including colon, esophageal, pancreatic, prost…
-
CLINICAL_TRIALS research · 2017-01-06Clinical Trial Update: Creation of the BioBank, Early Detection and Discovery Biomarkers
This completed clinical trial update describes the creation of a BioBank to support discovery of early-detection biomarkers for pancreatic c…
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Translational Research on Locally Advanced Pancreatic Adenocarcinoma [NA]
Clinical trial update focusing on translational research in locally advanced pancreatic adenocarcinoma; no phase information or trial status…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Pancreatico-biliary Tumor Mutation Profiling in Bile Samples
A completed clinical trial evaluated mutation profiling of pancreatico-biliary tumors using bile samples. It targeted cholangiocarcinoma and…
-
FDA approval · 2016-12-27FDA Approved: FLUOROURACIL — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Fluorouracil (5-fluorouracil) from Eugia US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas [Phase 3]
A Phase 3 trial evaluating surgery followed by radiation therapy and chemotherapy for pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-22Clinical Trial Update: Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer [Phase 2]
This entry reports a Phase 2 clinical trial evaluating nab-paclitaxel in combination with S-1 for advanced pancreatic cancer; the current tr…
-
CLINICAL_TRIALS trial_result · 2016-12-20Clinical Trial Update: Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer [Phase 1]
Phase 1 trial evaluating the combination of gemcitabine, 5-fluorouracil, and radiation therapy for non-metastatic pancreatic cancer has been…
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [NA]
This entry reports a completed clinical trial evaluating cetuximab with gemcitabine and oxaliplatin in locally advanced or metastatic pancre…
-
FDA approval · 2016-12-14FDA Approved: FLUOROURACIL — Supplemental Application (Eugia US LLC)
The FDA has approved a supplemental application for Fluorouracil from Eugia US LLC, formalizing an update to the product under the ANDA path…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). [Phase 1]
This Phase 1 study evaluated the combination of lurbinectedin with capecitabine in patients with metastatic breast cancer, pancreatic cancer…
-
CLINICAL_TRIALS trial_result · 2016-12-13Clinical Trial Update: Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 study evaluating Bevacizumab, Gemcitabine, and Oxaliplatin in metastatic pancreatic cancer has completed; the update outlines safe…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients [Phase 4]
Phase 4 trial completed and results posted evaluating dalteparin for primary venous thromboembolism prophylaxis in pancreatic cancer patient…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer [Phase 2]
Phase 2 trial update on neoadjuvant chemoradiation for potentially resectable pancreatic cancer, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients [Phase 2]
Phase 2 trial evaluating eribulin mesylate as second-line therapy for locally advanced, unresectable, or metastatic pancreatic cancer; the s…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma [Phase 1]
Phase 1 feasibility and safety study evaluating vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with metastatic or…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Early Palliative Care on Quality of Life of Advanced Cancer Patients [Phase 3]
A Phase 3 trial evaluating whether early palliative care improves quality of life in advanced cancers. The study includes non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer [Phase 2]
This phase 2 trial evaluated adjuvant chemoradiotherapy with interferon alfa in patients with resected pancreatic cancer; the study status i…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating induction chemotherapy followed by radiochemotherapy for locally advanced pancreatic cancer has completed. The st…
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor [Phase 1, Phase 2]
A Phase 1/2 trial evaluating CAR-pNK cell immunotherapy for MUC1-positive relapsed or refractory solid tumors; current status is not provide…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: Phase I/II Study of Anti-Mucin1 (MUC1) CAR T Cells for Patients With MUC1+ Advanced Refractory Solid Tumor [Phase 1, Phase 2]
Phase 1/2 trial evaluating Anti-Mucin1 (MUC1) CAR T cells in patients with MUC1-positive advanced refractory solid tumors across several can…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: IORT Versus CCRT for Pancreatic Cancer [NA]
This entry outlines a clinical trial comparing intraoperative radiotherapy (IORT) to concurrent chemoradiation (CCRT) for pancreatic cancer,…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Apatinib as Second-line Treatment of Advanced Pancreatic Cancer [Phase 2]
This document reports a Phase 2 trial of apatinib as second-line treatment for advanced pancreatic cancer. The current trial status is not d…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Pancreatic Resection, Malnutrition and Readmission [NA]
A Duke University-sponsored clinical trial evaluating the association of pancreatic resection, malnutrition, and readmission in pancreatic c…
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy [Phase 4]
Phase 4 trial update comparing early oral nutrition versus enteral feeding after pancreatoduodenectomy. The study includes patients with pan…